MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis

Medical Oncology

Volumn 29, Issue 3, 2012, Pages 1673-1680

  Chen, Lan Tao ^a   Xu, Shi Dong ^b   Xu, Hai ^b   Zhang, Jin Feng ^b   Ning, Jin Feng ^b   Wang, Sheng Fa ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; MicroRNAs; NSCLC

Indexed keywords

MICRORNA; MICRORNA 378; UNCLASSIFIED DRUG;

ADULT; ANGIOGENESIS; ARTICLE; BRAIN METASTASIS; CANCER INVASION; CANCER RISK; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CELL MOVEMENT; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 84872199112     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-0083-x     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. Cancer statistics,2007. CA Cancer J Clin. 2007;57(1):43-66.
2. Grinberg-Rashi H, Ofek E, Perelman M, Skarda J, Yaron P, et al. The expression of three genes in primary nonsmall cell lung cancer is associated with metastatic spread to the brain. Clin Cancer Res. 2009;15(5):1755-61.
3. Laack NN, Brown PD. Cognitive sequelae of brain radiation in adults. Semin Oncol. 2004;31(5):702-13.
4. Oh Y, Taylor S, Bekele BN, Debnam JM, Allen PK, et al. Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases. Cancer. 2009;115(13):2930-8.
5. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435(7043):834-8.
6. Liu CG, Calin GA, Volinia S, Croce CM. MicroRNA expression profiling using microarrays. Nat Protoc. 2008;3(4):563-78.
7. Lee DY, Deng Z, Wang CH, Yang BB. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci USA. 2007;104(51):20350-5.
8. Arora S, Ranade AR, Tran NL, Nasser S, Sridhar S, et al. MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration. Int J Cancer. 2011; [Epub ahead of print].
9. Schmittgen TD, Jiang J, Liu Q, Yang L. A high-throughput method to monitor the expression of microRNA precursors. Nucleic Acids Res. 2004;32(4):e43.
10. Coleman JE, Huentelman MJ, Kasparov S, Metcalfe BL, Paton JF, et al. Efficient large-scale production and concentration of HIV-1-based lentioviral vectors fr use in vivo. Physiol Genomics. 2003;12(3):221-8.
11. Hua Z, Lv Q, Ye W, Wong CK, Cai G, et al. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS ONE. 2006;1:e116.
12. Sheng W, Wang G, Wang Y, Liang J, Wen J, et al. Roles of versican V1 and V2 isoforms in cell proliferation and apoptosis. Mol Biol Cell. 2005;16(3):1330-40.
13. Saber T, Veale DJ, Balogh E, McCormick J, Nicanultaigh S, et al. Toll-like receptor 2 induced angiogenesis and invasion is mediated through the Tie2 signalling pathway in rheumatoid arthritis. PLoS One. 2011;6(8):e23540.
14. Chen Y, Jing Z, Luo C, Zhuang M, Xia J, et al. Vasculogenic mimicry-potential target for glioblastoma therapy: an in vitro and in vivo study. Med Oncol. 2010. doi:10.1007/s12032-010-9765-z.
15. Hallani SEI, Boisselier B, Peglion F, Rousseau A, Colin C, et al. A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry. Brain. 2010;133(Pt4):973-82.
16. Pugh TJ, Gaspar LE. Prophylactic cranial irradiation for patients with lung cancer. Clin Lung Cancer. 2007;8(6):365-8.
17. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281-97.
18. Jiang J, Lee EJ, Gusev Y, Schmittgen TD. Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res. 2005;33(17):5394-403.
19. Abdulrauf SI, Edvardsen K, Ho KL, Yang XY, Rock JP, et al. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with lowgrade astrocytoma. J Neurosurg. 1998;88(3):513-20.
20. Zhou D, Cheng SQ, Ji HF, Wang JS, Xu HT, et al. Evaluation of protein pigment epithelium-derived factor (PEDF) and microvessel density (MVD) as prognostic indicators in breast cancer. Cancer Res Clin Oncol. 2010;136(11):1719-27.
21. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol. 1999;155(3):739-52.
22. Sun B, Qie S, Zhang S, Sun T, Zhao X, et al. Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors. Hum Pathol. 2008;39(3):444-51.
23. Guzman G, Cotler SJ, Lin AY, Maniotis AJ, Folberg R. A pilot study of vasculogenic mimicry immunohistochemical expression in hepatocellular carcinoma. Arch Pathol Lab Med. 2007;131(12):1776-81.
24. Oka N, Soeda A, Inagaki A, Onodera M, Maruyama H, et al. VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells. Biochem Biophys Res Commun. 2007;360(3):553-9.